Schain Research

We help life science companies turn real-world data into strategic insights. With deep expertise in Real-World Evidence (RWE) and advanced analytics, we transform complex health data into decision-ready evidence that: • Drives innovation • Optimizes strategies • Improves patient outcomes. Our expertise spans the entire lifecycle of medicines—from early development to post-market access. We work closely with our clients to ensure their data supports regulatory approvals, market access, and effective clinical strategies. What Makes Us Unique? • A highly experienced team with deep scientific expertise – Our team includes PhD-level researchers specializing in epidemiology, biostatistics, health economics, and medical sciences. We work closely with clients to generate high-quality real-world evidence. • Nordic and global data expertise – Access to high-quality, population-based health data. • Regulatory and market access strategy – Strengthening evidence for approvals and commercialization. • Therapeutic focus – Expertise in oncology, rare diseases, neurology, immunology, cardiovascular, and metabolic diseases. Our proprietary EpiX platform enables fast, secure, and decision-ready analysis of real-world data—empowering our clients with the right evidence at the right time. We partner with pharmaceutical companies, biotech firms, and regulatory stakeholders to transform real-world evidence into real-world impact. Interested in leveraging Real-World Evidence for regulatory and market access success? Let’s connect at www.schainresearch.com or contact us at info@schainresearch.com.